Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950138-03-000504
Filing Date
2003-09-15
Accepted
2003-09-15 13:23:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 MISC\2003\SEPT 13G - ALFACELL - ROTH - STARK sept13g_alfacellroth-stark.txt SC 13G 10661
  Complete submission text file 0000950138-03-000504.txt   12580
Mailing Address 225 BELLEVILLE AVE 225 BELLEVILLE AVE BLOOMFIELD NJ 07003
Business Address 225 BELLEVILLE AVE BLOOMFIELD NJ 07003 9737488082
ALFACELL CORP (Subject) CIK: 0000708717 (see all company filings)

EIN.: 222369085 | State of Incorp.: DE | Fiscal Year End: 0731
Type: SC 13G | Act: 34 | File No.: 005-45232 | Film No.: 03895267
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 10556 N PORT WASHINGTON RD MEQUON WI 53092
Business Address 10556 N PORT WASHINGTON RD MEQUON WI 53092 4142411810
ROTH MICHAEL (Filed by) CIK: 0001010207 (see all company filings)